BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9534199)

  • 1. Immunohistochemical analysis of thyroid adenomas with Hurthle cells.
    Kanthan R; Radhi JM
    Pathology; 1998 Feb; 30(1):4-6. PubMed ID: 9534199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland.
    Czyz W; Kuzdak K; Pasieka Z; Timler D; Brzeziński J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():167-8. PubMed ID: 11820589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors.
    Judkins AR; Roberts SA; Livolsi VA
    Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
    Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
    Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
    Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE; Olsen KD; Sebo TJ
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
    Abu-Alfa AK; Straus FH; Montag AG
    Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenocarcinoma: a histological and immunohistochemical study.
    Ko CJ; Cochran AJ; Eng W; Binder SW
    J Cutan Pathol; 2006 Nov; 33(11):726-30. PubMed ID: 17083691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hurthle cell thyroid tumors. An immunohistochemical study.
    Johnson TL; Lloyd RV; Burney RE; Thompson NW
    Cancer; 1987 Jan; 59(1):107-12. PubMed ID: 3539304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid cell nests of the thyroid. A histologic and immunohistochemical study.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Hashimoto T; Nakamura S; Ishizaki T
    Am J Clin Pathol; 1994 Feb; 101(2):186-91. PubMed ID: 7509563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
    Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
    Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component.
    Stead RH; Qizilbash AH; Kontozoglou T; Daya AD; Riddell RH
    Hum Pathol; 1988 Jan; 19(1):32-40. PubMed ID: 2447009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hürthle cell neoplasms of the thyroid gland: an immunohistochemical study.
    Chetty R
    Histopathology; 1990 Oct; 17(4):368-70. PubMed ID: 2258175
    [No Abstract]   [Full Text] [Related]  

  • 17. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
    Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
    J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseases.
    Kazakov SP; Zabotina TN; Korotkova OV; Dzabarov AK; Kazantseva IA
    Bull Exp Biol Med; 2011 Feb; 150(4):453-8. PubMed ID: 22268042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.